Health and Equity in Chicago: Health in All Policies and the Englewood Line Trail Health Impact Assessment
The session will highlight the Englewood Line Trail Health Impact Assessment (HIA) that is being conducted to inform development along a disused rail line that runs through Chicago’s Englewood and West Englewood communities. In order to provide recommendations that are evidence-based, actionable and reflective of community priorities, the Englewood Line Trail HIA process is rooted in strong collaboration between City agencies, public health partners and community stakeholders and residents. The Englewood Line Trail is in early stages of development, so the HIA is able to provide recommendations related to short-term and long-term aspects of the trail development including: trail design to address community safety, plans to incorporate workforce development into the trail’s creation, community cohesion, a vision for urban agriculture and community revitalization, and environmental health.
Learning Areas:Other professions or practice related to public health
Describe how urban agriculture can foster community health Discuss the use of community organizing to promote health equity in communities Discuss the use of HIA as a tool in Health in All Policies work Discuss the importance of community expertise to the HIA process and in the creation of healthy communities overall Identify strategies that promote the integration of health into decision-making across sectors Demonstrate how to incorporate the consideration of health issues into land use planning
Keyword(s): Built Environment, Health Assessment
Qualified on the content I am responsible for because: I'm a public health professional with 12 years of experience at the Chicago Department of Public Health. I am lead staff for the Department on our Englewood Line Trail Health Health Impact Assessment project.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.